PTGER4 and neoplasm: (122) conducted a receptor−ligand pairing analysis through a large-scale clinical single-cell transcriptomic analysis and found that the OPN-PTGER4 ligand−receptor pair is associated with CD8+ T lymphocyte dysfunction, immunosuppressive states, and late-stage tumor development.